UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Neurourology and urodynamics, 2014-01, Vol.33 (1), p.17-30

2014

Volltextzugriff (PDF)

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder

European urology, 2013-02, Vol.63 (2), p.296-305

2013

Volltextzugriff (PDF)

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

European urology, 2020-01, Vol.77 (1), p.119-128

2020

Volltextzugriff (PDF)

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

BJU international, 2017-10, Vol.120 (4), p.562-575

2017

Volltextzugriff (PDF)

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

European urology, 2019-03, Vol.75 (3), p.464-476

2019

Volltextzugriff (PDF)

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

BJU international, 2015-06, Vol.115 (6), p.968-977

2015

Volltextzugriff (PDF)

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

European urology focus, 2019-03, Vol.5 (2), p.280-289

2019

Volltextzugriff (PDF)

A phase II dose-ranging study of mirabegron in patients with overactive bladder

International Urogynecology Journal, 2013-09, Vol.24 (9), p.1447-1458

2013

Volltextzugriff (PDF)

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

BJU international, 2017-11, Vol.120 (5), p.611-622

2017

Volltextzugriff (PDF)

A proof-of-concept study: Mirabegron, a new therapy for overactive bladder

Neurourology and urodynamics, 2013-11, Vol.32 (8), p.1116-1122

2013

Volltextzugriff (PDF)

The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis

European urology, 2005-07, Vol.48 (1), p.5-26

2005

Volltextzugriff (PDF)

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Neurourology and urodynamics, 2012-01, Vol.31 (1), p.13-21

2012

Volltextzugriff (PDF)

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S6-S13

Chapple, Christopher

2014

Volltextzugriff (PDF)

Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement

World journal of urology, 2013-08, Vol.31 (4), p.997-1008

2013

Volltextzugriff (PDF)

Comparison of fesoterodine and tolterodine in patients with overactive bladder

BJU international, 2008-11, Vol.102 (9), p.1128-1132

2008

Volltextzugriff (PDF)

The placebo effect in overactive bladder syndrome

Nature reviews. Urology, 2011-09, Vol.8 (9), p.495-503

2011

Volltextzugriff (PDF)

Patient-reported outcomes in overactive bladder: Importance for determining clinical effectiveness of treatment

Urology (Ridgewood, N.J.), 2006-08, Vol.68 (2), p.3-8

2006

Volltextzugriff (PDF)

Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH

World journal of urology, 2015-05, Vol.33 (5), p.697-706

2015

Volltextzugriff (PDF)

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin

BJU international, 2005-01, Vol.95 (1), p.81-85

2005

Volltextzugriff (PDF)

Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration

BJU international, 2010-11, Vol.106 (9), p.1332-1338

2010

Volltextzugriff (PDF)

Stress Incontinence Injection Therapy: What is Best for Our Patients?

European urology, 2005-10, Vol.48 (4), p.552-565

2005

Volltextzugriff (PDF)

Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004)

European urology, 2006-05, Vol.49 (5), p.879-886

2006

Volltextzugriff (PDF)

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

European urology, 2005-09, Vol.48 (3), p.488-494

2005

Volltextzugriff (PDF)

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S1-S1

Chapple, Christopher

2014

Volltextzugriff (PDF)

A prospective, randomized, double‐blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome

BJU international, 2007-02, Vol.99 (2), p.355-359

2007

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaTreatment Outcome

ThemaUrology & Nephrology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Female
(22)
Male
(22)
Middle Aged
(18)
Aged
(17)
Adult
(15)
Quality Of Life
(15)
Urinary Bladder, Overactive - Drug Therapy
(15)
Urinary Incontinence
(12)
Double-Blind Method
(11)
Overactive Bladder
(11)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Muscarinic Antagonists - Therapeutic Use
(9)
Acetanilides - Therapeutic Use
(8)
Thiazoles - Therapeutic Use
(8)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review

Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women

Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair

A phase II dose-ranging study of mirabegron in patients with overactive bladder

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis

A proof-of-concept study: Mirabegron, a new therapy for overactive bladder

The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis

Are biomechanical properties predictive of the success of prostheses used in stress urinary incontinence and pelvic organ prolapse? A systematic review

Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of "Overactive bladder"

Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement

Comparison of fesoterodine and tolterodine in patients with overactive bladder

The placebo effect in overactive bladder syndrome

Patient-reported outcomes in overactive bladder: Importance for determining clinical effectiveness of treatment

Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin

Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration

Stress Incontinence Injection Therapy: What is Best for Our Patients?

Effect of an ATP-Sensitive Potassium Channel Opener in Subjects with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Study (ZD0947IL/0004)

An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary Incontinence

Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder

A prospective, randomized, double‐blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome

Aktive Filter

Suchergebnisse filtern